Pharmacodynamics Flashcards

1
Q

What are the three steps of cell signalling?

A
  1. Reception
  2. Transduction
  3. Response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a dose?

What is Concentration?

What is Potency?

A

Dose
- The amount of a drug given to a patient

Concentration
- The amount of something the body produces after a given dose
- Emax is the maximum amount of something produced

Potency
- How much drug is needed to achieve an effect
- EC50 (50% effect) is how big a dose is required to give 50% of its effect
- The lower the dose required to achieve the same EC50, the more potent a drug is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the four main drug targets?

Where in relation to a cell are they usually found, and why are they targeted?

A

Main drug targets
1. Enzymes
2. Carrier Proteins
3. Ion channels
4. Receptors (Most common)

These are usually found on the cell surface because it’s easier to interact with them than intracellular proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How many binding sites do receptors have?

What is the chemical that binds to a binding site called?

What is required for these to bind to binding sites?

A

Receptors have at least 1 binding site

Chemicals that bind to a binding site are called ligands and they require affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens when a ligand binds to a receptor?

What is efficacy?

A

An intracellular signalling pathway is triggered when a ligand binds to a receptor

Efficacy is the ability of a ligand to trigger an intracellular signalling pathway
Maximum efficacy = 1
No effect = 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can drugs interact with signal transduction?

A

Drugs can either promote or inhibit signal transduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is ligand/receptor selectivity/affinity determined by?

A

It’s determined by the shapes of the ligand and binding sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 main groups of receptors and what are their associated signalling pathways?

A
  1. Ionotropic - Linked to ion channels
  2. Metabotropic - Linked to G-proteins (G protein-coupled)
  3. Kinase-linked - Linked to certain enzymes
  4. Nuclear/intracellular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the timeframes of action for the 4 main groups of receptors, and what do they typically do to the cell?

A
  1. Ionotropic - Miliseconds, causing hyperpolarisation or depolarisation
  2. Metabotropic - Seconds, linked to protein phosphorylation
  3. Kinase-linked - Hours, causing gene transcription and protein synthesis
  4. Nuclear/intracellular - Hours to days, causing gene transcription and protein synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Do agonistic drugs have receptor affinity and/or efficacy?

Do antagonistic drugs have receptor affinity and/or efficacy?

A

Agonistic drugs have receptor affinity and efficacy
- Produces a cell signalling response

Antagonistic drugs have receptor affinity but no efficacy
- Binds to the receptor and blocks to it so nothing else can bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is receptor basal response?

What is an Inverse agonist?

A

Basal response is the low level of activity a receptor may exhibit without the binding of a ligand

An inverse agonist is a drug that eliminates this basal low level activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What types of competitiveness are present in antagonists?

A

Reversible, irreversible, and non-competitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is competitive antagonism (reversible and irreversible)?

A

Competitive antagonism is when the agonist and antagonist are competing for the same binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What differentiates reversible and irreversible competitive antagonism?

A

Reversible competitive antagonism
- Antagonist binds and releases to the binding site and prevents agonist binding when the antagonist is in the binding site
- Emax is still achieved but just requires a higher concentration

Irreversible competitive antagonism
- Antagonist binds with a covalent bond and doesn’t leave the binding site, disabling that receptor
- Emax is not achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is non-competitive antagonism?

What is a common drug example?

A

Non-competitive antagonism is when the antagonist doesn’t compete for the same binding site but interferes with the signalling pathway or effects afterwards

A common example is calcium channel blockers for hypertension

Emax is not achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the approximate life of a receptor in the body?

A

Around a week

17
Q

What are some examples of reversible competitive antagonists?

A

Loratidine
Cetirizine
Metoprolol

18
Q

What is an example of an irreversible competitive antagonist?

A

Clopidogrel

19
Q

What is an example of a non-competitive antagonist?

A

Verapamil

20
Q

What is receptor plasticity?

A

The idea that receptor states and populations don’t remain constant over time

21
Q

What is desensitisation?

A

A response to short-term agonist exposure (several seconds) in which some of the receptors present in the cell membrane are turned off and can’t undergo transduction

22
Q

What are up-regulation and down-regulation?

A

Up-regulation
- A response to long-term antagonist exposure
- An increase in receptor population

Down-regulation
- A response to long-term agonist exposure
- An decrease in receptor population

23
Q

What is a drug example of chronic agonist administration that can lead to down-regulation?

A

Chronic use of salbutamol triggers down-regulation of B2 receptors in the lungs and an eventual decrease in drug effect (less bronchodilation)

24
Q

What is a drug example of chronic antagonist administration that can lead to up-regulation?

A

Chronic use of metoprolol triggers up-regulation of B1 receptors in the heart and an eventual decrease in drug effect (increase in heart rate and blood pressure)

25
Q

Which type of antagonist is least likely to be used?

What is a drug exception to this, and why?

A

Irreversible competitive antagonists are least likely to be used because of their irreversible nature

An exception to this is clopidogrel, as it acts on receptors on platelets, which are renewed daily, so adverse effects will wane after 24 hours.

26
Q

What do enzymes do?

A

Enzymes catalyse reactions and speed them up

27
Q

What are some examples of enzyme targets, and what drugs target them?

A

Cyclooxygenase is an enzyme key in prostaglandin synthesis
- Non-steroidal anti-inflammatory drugs (e.g. ibuprofen, celecoxib) target cyclooxygenase to reduce pain and inflammation

HMG CoA Reductase is an enzyme key in cholesterol synthesis
- Statins (e.g. atorvastatin) target HMG CoA reductase to reduce cholesterol levels

28
Q

Which type of cyclooxygenase also affects kidney and gastrointestinal homeostatic pathways?

Which type of cyclooxygenase affects the cardiovascular system?

A

COX1 inhibitors affect kidney function and increase gastric acid secretion

COX2 inhibitors (e.g. celecoxib) have greater GI safety but increase the chance of cardiac events such as myocardial infarction

29
Q

What are some examples of drugs which interact with carrier proteins?

A

Drugs that act on monoamine neurotransmitter uptake proteins

Selective Serotonin Reuptake Inhibitors - e.g. Fluoxetine
Selective Noradrenaline Reuptake Inhibitors - e.g. Sibutramine

Bupropion - Smoking cessation

30
Q

What is fluoxetine and how does it work?

A

Fluoxetine is a selective serotonin reuptake inhibitor used as an antidepressant.

It blocks the reuptake of serotonin back into the presynaptic neuron, prolonging the duration of serotonin staying in the synapse

The prolonged presence of serotonin in the synapse is theorised to trigger the down-regulation of pre-synaptic serotonin receptors, reducing serotonin reuptake and producing the antidepressant effect

31
Q

What are the primary ion channels that are targeted, and what drugs typically target them?

A

Sodium channels
- Targeted by sodium channel blockers (Lignocaine, sodium valproate)

Calcium channels
- Targeted by calcium channel blockers (Verapamil, nifedipine)

32
Q

Lignocaine and Sodium Valproate are Sodium channel blockers. What are they used for, and how do they work?

A

Sodium channel blockers block the sodium channels that neurons use to transmit action potentials

Lignocaine - Local anaesthetic
- Blocks pain nerves from sending signals to the brain

Sodium Valproate - Anti-convulsant for treating epilepsy
- Prevents/inhibits overexcitation of the brain

33
Q

How are drug targets classified?

A

Drug targets belong to broad families and sometimes sub-families, from which there can be subtypes

e.g.
Family: Histamine receptors

Subtypes: H1, H2, H3

e.g.
Family: Adrenergic receptors

Sub-Families: Alpha and Beta

Subtypes: a1, a2, b1, b2, b3

34
Q

What is drug selectivity? What are drug examples of drugs exhibiting selectivity?

A

Drug selectivity is the preferential binding of a drug to a specific subtype leading to a greater effect being produced from that subtype than from others

Salbutamol targets b2 receptors (lungs) more than it does b1 receptors (heart)

Antiallergy antihistamines target h1 receptors